Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
about
Preparation and in vitro evaluation of anti-VCAM-1-Fab'-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib.Multifunctional, stimuli-sensitive nanoparticulate systems for drug deliveryEnhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer.Improving selective targeting to macrophage subpopulations through modifying liposomes with arginine based materials.Liposomal Doxorubicin in the treatment of breast cancer patients: a reviewMicroemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.Advances in novel drug delivery strategies for breast cancer therapy.The treatment of breast cancer using liposome technology.Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.Current trends in the use of liposomes for tumor targetingFunctional liposomes in the cancer-targeted drug delivery.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Mechanistic Investigation and Multiplexing of Liposome-Assisted Metabolic Glycan Labeling.Stimuli-free programmable drug release for combination chemo-therapy.l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells
P2860
Q33852343-1615656C-D596-4868-BA6B-2365491AA507Q35809872-1A0B4696-B0A3-4A13-9728-E5A9CC548AFEQ36177559-BCE3A8ED-D711-4369-A8AA-7A14ECCA027EQ36191455-29D67767-5F97-422C-9113-FEDD83705598Q36748268-84301881-1FBD-498A-8FDA-B5FC9A0969E4Q37702234-88307076-8A97-4BBE-B099-233EEB0AD8A4Q37777142-366D1BC8-7860-4B67-A138-941921B132BFQ38002854-79D62E72-BF23-4596-BABA-88F5AE5D3303Q38074442-E6E477E7-F997-4E56-83CD-204860B62F77Q38126543-18DAD414-C577-476D-88E0-98F80874F088Q38396298-2A8BC0D5-EDC3-4434-92AF-ECE8210CEC25Q38597794-6D25204B-DBC3-47A9-95F2-83A5D0EF8065Q49987131-A807FEF6-F67F-4F02-BBF5-DCD984171C16Q53288917-4B4740BD-B40F-4A61-AE9D-DB56F82091B9Q57369521-1C973BD0-CD61-43AB-A74D-299462839105
P2860
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
@en
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
@nl
type
label
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
@en
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
@nl
prefLabel
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
@en
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
@nl
P2093
P1476
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
@en
P2093
Dapeng Zhang
Guichen Zhou
P304
P356
10.1016/J.IJPHARM.2009.03.018
P407
P50
P577
2009-03-24T00:00:00Z